- Amgen Inc.
- Genentech Inc.
- Merck & Co. Inc.
- Merck Research Laboratories
- Immunex Corp.
- AstraZeneca PLC
- ImClone Systems Inc.
- Genzyme Corp.
- Genzyme Drug Discovery & Development
- NPS Pharmaceuticals Inc.
- Swedish Orphan Biovitrum AB
- Tularik Inc.
- NeoGenesis Pharmaceuticals Inc.
- Infinity Pharmaceuticals Inc.
- Biogen Inc.
- Amgen to acquire Synergen for $239.6 million
- Amgen pays $170mm for Kinetix
- Amgen buys Immunex in $17.9bn cash and stock deal
- Genzyme to buy GelTex in $1bn cash/stock deal
- Amgen develops NPS Pharmaceuticals' calcium receptor tech.
- Amgen and Biovitrum sign license agreements
- Tularik, Amgen discover and develop cancer therapeutics
- Amgen and NeoGenesis enter drug discovery deal
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.